These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31826553)

  • 41. Effect of membrane thickness of collodion coated activated charcoal on adsorption of small and middle molecules.
    Morley D; Chang TM
    Biomater Artif Cells Artif Organs; 1987; 15(3):617-32. PubMed ID: 3440135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Charcoal hemoperfusion for chronic renal failure.
    Siemsen AW; Dunea G; Mamdani BH; Guruprakash G
    Nephron; 1978; 22(4-6):386-90. PubMed ID: 740102
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hemoperfusion with XAD-4 resin in the treatment of a severe parathion intoxication (author's transl)].
    Pentz R; Brunn J
    Arch Toxicol; 1979 Sep; 42(4):311-5. PubMed ID: 518296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of hemoperfusion with coated and uncoated charcoal on human blood in vitro.
    Ott NT; Kohnle W; Scheck R; Konstantin P; Franz HE
    J Dial; 1979; 3(4):291-308. PubMed ID: 263952
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical experience with charcoal and resin hemoperfusion.
    Hughes R; Williams R
    Semin Liver Dis; 1986 May; 6(2):164-73. PubMed ID: 3018936
    [No Abstract]   [Full Text] [Related]  

  • 46. Evaluation of the in vitro efficacy of hemodialysis, hemoperfusion, and the combined approach on the removal of metaldehyde from canine plasma.
    Mauser EL; Puschner B; Reese S; Hartmann K; Doerfelt R
    J Vet Emerg Crit Care (San Antonio); 2016 Jul; 26(4):516-23. PubMed ID: 27219514
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Delayed peak serum valproic acid in massive divalproex overdose--treatment with charcoal hemoperfusion.
    Graudins A; Aaron CK
    J Toxicol Clin Toxicol; 1996; 34(3):335-41. PubMed ID: 8667473
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vibrofluidized bed coating of hemoperfusion adsorbents.
    Morley DB
    ASAIO Trans; 1989; 35(2):139-43. PubMed ID: 2730812
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Removal of inhibitors of brain Na+, K+-ATPase by hemoperfusion in fulminant hepatic failure.
    Seda HW; Hughes RD; Gove CD; Williams R
    Artif Organs; 1984 May; 8(2):174-8. PubMed ID: 6329147
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ACAC (albumin-collodion coated activated charcoal) hemoperfusion: in-vitro removal and clearance of theophylline.
    Espinosa-Meléndez E; Chang TM
    J Dial; 1980; 4(1):21-9. PubMed ID: 7410675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synergistic effect of Ficus-zero valent iron supported on adsorbents and
    Romeh AA
    Int J Phytoremediation; 2021; 23(2):151-161. PubMed ID: 32772548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Direct hemoperfusion with noncoated charcoal of high adsorption capacity derived from thermosetting resin.
    Otsubo O; Horiuchi T; Uchima T; Takai N; Tsunetsugu T; Inou T
    Trans Am Soc Artif Intern Organs; 1980; 26():124-8. PubMed ID: 7245468
    [No Abstract]   [Full Text] [Related]  

  • 53. In vitro and clinical studies of the removal of cortisol, thyroxine, insulin, and thyroid-stimulating hormone by coated charcoal haemoperfusion.
    Dixit V; Chang TM
    Life Support Syst; 1984; 2(4):238-44. PubMed ID: 6396457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Problems of competition in charcoal hemoperfusion for the treatment of intoxications.
    Gundermann KJ; Lie TS
    Artif Organs; 1979 Nov; 3(4):346-9. PubMed ID: 533425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting Albumin Binding Function as a Therapy Goal in Liver Failure: Development of a Novel Adsorbent for Albumin Dialysis.
    Dominik A; Stange J; Baumann AK; Pfensig C; Suraj M; Ibrahim B; Eggert M
    Ther Apher Dial; 2018 Apr; 22(2):196-204. PubMed ID: 29266788
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Removal of bacteria from blood by charcoal hemoperfusion.
    Marks DH; Medina F; Lee S; Blackmon A; Schuschereba ST
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):135-40. PubMed ID: 3052639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Construction of Kevlar nanofiber/graphene oxide composite beads as safe, self-anticoagulant, and highly efficient hemoperfusion adsorbents.
    Yang Y; Yin S; He C; Wu X; Yin J; Zhang J; Ma L; Zhao W; Cheng C; Zhao C
    J Mater Chem B; 2020 Mar; 8(9):1960-1970. PubMed ID: 32067017
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Albumin, bilirubin, and activated carbon: new edges of an old triangle.
    Sarnatskaya VV; Lindup WE; Walther P; Maslenny VN; Yushko LA; Sidorenko AS; Nikolaev AV; Nikolaev VG
    Artif Cells Blood Substit Immobil Biotechnol; 2002 Mar; 30(2):113-26. PubMed ID: 12027227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preparation and performance of chitosan encapsulated activated charcoal (ACCB) adsorbents for small molecules.
    Chandy T; Sharma CP
    J Microencapsul; 1993; 10(4):475-86. PubMed ID: 8263676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coating charcoal with polyacrylate-polymethacrylate copolymer for haemoperfusion. III: The effect of the coat thickness on the adsorptioncapacity of the coated charcoal and its adsorptivity to small and middle size molecules.
    el-Kheshen S; Zia H; Badawi A; Needham TE; Luzzi LA
    J Microencapsul; 1995; 12(5):505-14. PubMed ID: 8544094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.